Literature DB >> 7000216

Tromboxane B2 inhibits the pulmonary inactivation of prostaglandin E2 in the dog.

T M Fitzpatrick, L S Friedman, P A Kot, P W Ramwell.   

Abstract

1 The systemic vasodepressor response to intravenously administered prostaglandin E2 (PGE2, 0.3, 1.0 and 3.0 micrograms/kg) is potentiated during intravenous infusion of thromboxane B2 (TXB2, 1.0 micrograms kg-1 min-1) in the anaesthetized dog. 2 The augmented haemodynamic response returns toward control values following cessation of the TXB2 infusion. 3 The systemic haemodynamic responses to intra-arterially administered PGE2, PGF2 alpha and PGI2 as well as intravenously administered PGF2 alpha and PGI2 are not altered by TXB2 infusion. 4. This study suggests that TXB2 inhibits the pulmonary inactivation of PGE2. 5 Arachidonic acid metabolites may interact, producing haemodynamic responses differing from their individual effects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000216      PMCID: PMC2044335          DOI: 10.1111/j.1476-5381.1980.tb07935.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Metabolism of prostacyclin. Oxidation by rhesus monkey lung 15-hydroxyl prostaglandin dehydrogenase.

Authors:  J C McGuire; F F Sun
Journal:  Arch Biochem Biophys       Date:  1978-07       Impact factor: 4.013

2.  Metabolism of prostacyclin in blood vessels.

Authors:  P Y Wong; F F Sun; J C McGiff
Journal:  J Biol Chem       Date:  1978-08-25       Impact factor: 5.157

3.  Relationship of TXB2 and 6-keto PGF1 alpha to the hemodynamic changes during baboon endotoxic shock.

Authors:  R H Harris; M Zmudka; Y Maddox; P W Ramwell; J R Fletcher
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1980

4.  Clinically-used dyes are inhibitors of prostaglandin E2 inactivation in rat isolated lung [proceedings].

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

5.  Inhibition of prostaglandin-induced pulmonary vasoconstriction by organic acid transport inhibitors.

Authors:  T C Wicks; P W Ramwell; P A Kot; J C Rose
Journal:  Proc Soc Exp Biol Med       Date:  1978-04

Review 6.  Prostaglandins, their intermediates and precursors: cardiovascular actions and regulatory roles in normal and abnormal circulatory systems.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Prog Cardiovasc Dis       Date:  1979 May-Jun       Impact factor: 8.194

7.  Thromboxane B2 inhibits prostaglandin E2 inactivation by the rat isolated perfused lung.

Authors:  A L Boura; R D Murphy
Journal:  Clin Exp Pharmacol Physiol       Date:  1978 Jul-Aug       Impact factor: 2.557

8.  Recirculation of prostacyclin (PGI2) in the dog.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

9.  Biotransformation and cardiovascular effects of arachidonic acid in the dog.

Authors:  K M Mullane; G J Dusting; J A Salmon; S Moncada; J R Vane
Journal:  Eur J Pharmacol       Date:  1979-03-01       Impact factor: 4.432

10.  Biosynthesis of prostaglandins from arachidonic acid in guinea pig lung. Prostaglandins and related factors. 38.

Authors:  E Anggård; B Samuelsson
Journal:  J Biol Chem       Date:  1965-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.